Literature DB >> 20363751

Regulation of cardiomyocyte Glut4 expression by ZAC1.

Michael P Czubryt1, Lise Lamoureux, Angela Ramjiawan, Bernard Abrenica, Jaganmohan Jangamreddy, Kristin Swan.   

Abstract

The transcription factor ZAC1 is expressed in a variety of tissues including the developing heart, but its physiological role is unclear. We examined the role of ZAC1 in regulating expression of the insulin-responsive glucose transporter GLUT4 and whether ZAC1 expression is altered in cardiomyocyte hypertrophy. We demonstrated expression of Zac1 mRNA and protein in rat cardiomyocytes by PCR and Western blotting, respectively. Using a combination of chromatin immunoprecipitation and luciferase assays, we showed that ZAC1 regulates Glut4 expression via a specific binding site in the Glut4 promoter. Overexpression of ZAC1 increased Glut4 mRNA and protein expression and resulted in increased glucose uptake in cardiomyocytes as determined by a fluorescent analog uptake assay. Induction of hypertrophy by phenylephrine or isoproterenol resulted in increased Zac1 expression. We identified a novel putative promoter in the Zac1 gene and demonstrated increased binding of MEF2 to this promoter in response to hypertrophic stimulation. MEF2 regulated transactivation of the Zac1 promoter and ZAC1 protein expression. This work identifies ZAC1 as a novel and previously unknown regulator of cardiomyocyte Glut4 expression and glucose uptake. Our results also implicate MEF2 as a regulator of ZAC1 expression in response to induction of hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363751      PMCID: PMC2878075          DOI: 10.1074/jbc.M109.097246

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1.

Authors:  L F Michael; Z Wu; R B Cheatham; P Puigserver; G Adelmant; J J Lehman; D P Kelly; B M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities.

Authors:  B Bilanges; A Varrault; A Mazumdar; C Pantaloni; A Hoffmann; J Bockaert; D Spengler; L Journot
Journal:  Oncogene       Date:  2001-03-08       Impact factor: 9.867

3.  The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter.

Authors:  S Mora; J E Pessin
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

4.  Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus.

Authors:  A Varrault; B Bilanges; D J Mackay; E Basyuk; B Ahr; C Fernandez; D O Robinson; J Bockaert; L Journot
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

5.  Mouse Zac1, a transcriptional coactivator and repressor for nuclear receptors.

Authors:  S M Huang; M R Stallcup
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.

Authors:  R Passier; H Zeng; N Frey; F J Naya; R L Nicol; T A McKinsey; P Overbeek; J A Richardson; S R Grant; E N Olson
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

7.  The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation.

Authors:  S L Chen; D H Dowhan; B M Hosking; G E Muscat
Journal:  Genes Dev       Date:  2000-05-15       Impact factor: 11.361

8.  Regulation of proliferation of the fetal myocardium.

Authors:  M T Armstrong; D Y Lee; P B Armstrong
Journal:  Dev Dyn       Date:  2000-10       Impact factor: 3.780

9.  Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation.

Authors:  T A McKinsey; C L Zhang; J Lu; E N Olson
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

Review 10.  Early origins of cardiac hypertrophy: does cardiomyocyte attrition programme for pathological 'catch-up' growth of the heart?

Authors:  Enzo R Porrello; Robert E Widdop; Lea M D Delbridge
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-08-26       Impact factor: 2.557

View more
  6 in total

Review 1.  PLAGL1: an important player in diverse pathological processes.

Authors:  Ana F Vega-Benedetti; Cinthia Saucedo; Patrizia Zavattari; Roberta Vanni; José L Zugaza; Luis Antonio Parada
Journal:  J Appl Genet       Date:  2016-06-16       Impact factor: 3.240

2.  Altered expression of the imprinted transcription factor PLAGL1 deregulates a network of genes in the human IUGR placenta.

Authors:  Isabel Iglesias-Platas; Alex Martin-Trujillo; Paolo Petazzi; Amy Guillaumet-Adkins; Manel Esteller; David Monk
Journal:  Hum Mol Genet       Date:  2014-07-03       Impact factor: 6.150

3.  Zac1 regulates IL-11 expression in osteoarthritis.

Authors:  Chun-Lin Kuo; Shu-Ting Liu; Yung-Lung Chang; Chia-Chun Wu; Shih-Ming Huang
Journal:  Oncotarget       Date:  2018-08-21

4.  Arid1a-Plagl1-Hh signaling is indispensable for differentiation-associated cell cycle arrest of tooth root progenitors.

Authors:  Jiahui Du; Junjun Jing; Yuan Yuan; Jifan Feng; Xia Han; Shuo Chen; Xiang Li; Weiqun Peng; Jian Xu; Thach-Vu Ho; Xinquan Jiang; Yang Chai
Journal:  Cell Rep       Date:  2021-04-06       Impact factor: 9.423

5.  Plag1 and Plagl2 have overlapping and distinct functions in telencephalic development.

Authors:  Lata Adnani; Rajiv Dixit; Xingyu Chen; Anjali Balakrishnan; Harshil Modi; Yacine Touahri; Cairine Logan; Carol Schuurmans
Journal:  Biol Open       Date:  2018-11-26       Impact factor: 2.422

6.  Transcription Factor PLAGL1 Is Associated with Angiogenic Gene Expression in the Placenta.

Authors:  Rebekah R Starks; Rabab Abu Alhasan; Haninder Kaur; Kathleen A Pennington; Laura C Schulz; Geetu Tuteja
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.